Cargando…
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can be asymptomatic or cause a disease (COVID-19) characterized by different levels of severity. The main cause of severe COVID-19 and death is represented by acute (or acute on chronic) respiratory failure and acute respirat...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027286/ https://www.ncbi.nlm.nih.gov/pubmed/36941580 http://dx.doi.org/10.1186/s12950-023-00333-2 |
_version_ | 1784909692836773888 |
---|---|
author | Scaramuzzo, Gaetano Nucera, Francesco Asmundo, Alessio Messina, Roberto Mari, Matilde Montanaro, Federica Johansen, Matt D. Monaco, Francesco Fadda, Guido Tuccari, Giovanni Hansbro, Nicole G. Hansbro, Philip M. Hansel, Trevor T. Adcock, Ian M. David, Antonio Kirkham, Paul Caramori, Gaetano Volta, Carlo Alberto Spadaro, Savino |
author_facet | Scaramuzzo, Gaetano Nucera, Francesco Asmundo, Alessio Messina, Roberto Mari, Matilde Montanaro, Federica Johansen, Matt D. Monaco, Francesco Fadda, Guido Tuccari, Giovanni Hansbro, Nicole G. Hansbro, Philip M. Hansel, Trevor T. Adcock, Ian M. David, Antonio Kirkham, Paul Caramori, Gaetano Volta, Carlo Alberto Spadaro, Savino |
author_sort | Scaramuzzo, Gaetano |
collection | PubMed |
description | The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can be asymptomatic or cause a disease (COVID-19) characterized by different levels of severity. The main cause of severe COVID-19 and death is represented by acute (or acute on chronic) respiratory failure and acute respiratory distress syndrome (ARDS), often requiring hospital admission and ventilator support. The molecular pathogenesis of COVID-19-related ARDS (by now termed c-ARDS) is still poorly understood. In this review we will discuss the genetic susceptibility to COVID-19, the pathogenesis and the local and systemic biomarkers correlated with c-ARDS and the therapeutic options that target the cell signalling pathways of c-ARDS. |
format | Online Article Text |
id | pubmed-10027286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100272862023-03-21 Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance Scaramuzzo, Gaetano Nucera, Francesco Asmundo, Alessio Messina, Roberto Mari, Matilde Montanaro, Federica Johansen, Matt D. Monaco, Francesco Fadda, Guido Tuccari, Giovanni Hansbro, Nicole G. Hansbro, Philip M. Hansel, Trevor T. Adcock, Ian M. David, Antonio Kirkham, Paul Caramori, Gaetano Volta, Carlo Alberto Spadaro, Savino J Inflamm (Lond) Review The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can be asymptomatic or cause a disease (COVID-19) characterized by different levels of severity. The main cause of severe COVID-19 and death is represented by acute (or acute on chronic) respiratory failure and acute respiratory distress syndrome (ARDS), often requiring hospital admission and ventilator support. The molecular pathogenesis of COVID-19-related ARDS (by now termed c-ARDS) is still poorly understood. In this review we will discuss the genetic susceptibility to COVID-19, the pathogenesis and the local and systemic biomarkers correlated with c-ARDS and the therapeutic options that target the cell signalling pathways of c-ARDS. BioMed Central 2023-03-20 /pmc/articles/PMC10027286/ /pubmed/36941580 http://dx.doi.org/10.1186/s12950-023-00333-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Scaramuzzo, Gaetano Nucera, Francesco Asmundo, Alessio Messina, Roberto Mari, Matilde Montanaro, Federica Johansen, Matt D. Monaco, Francesco Fadda, Guido Tuccari, Giovanni Hansbro, Nicole G. Hansbro, Philip M. Hansel, Trevor T. Adcock, Ian M. David, Antonio Kirkham, Paul Caramori, Gaetano Volta, Carlo Alberto Spadaro, Savino Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance |
title | Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance |
title_full | Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance |
title_fullStr | Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance |
title_full_unstemmed | Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance |
title_short | Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance |
title_sort | cellular and molecular features of covid-19 associated ards: therapeutic relevance |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027286/ https://www.ncbi.nlm.nih.gov/pubmed/36941580 http://dx.doi.org/10.1186/s12950-023-00333-2 |
work_keys_str_mv | AT scaramuzzogaetano cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT nucerafrancesco cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT asmundoalessio cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT messinaroberto cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT marimatilde cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT montanarofederica cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT johansenmattd cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT monacofrancesco cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT faddaguido cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT tuccarigiovanni cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT hansbronicoleg cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT hansbrophilipm cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT hanseltrevort cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT adcockianm cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT davidantonio cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT kirkhampaul cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT caramorigaetano cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT voltacarloalberto cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance AT spadarosavino cellularandmolecularfeaturesofcovid19associatedardstherapeuticrelevance |